Ranitidine Hydrochloride Capsules

This product is an H2 receptor inhibitor, which has the effect of inhibiting gastric acid secretion. It is rapidly absorbed through the gastrointestinal tract after oral administration.

The main ingredient of this product is: Ranitidine hydrochloride. Its chemical name is: N'-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride. Molecular formula: C13H22N4O3SHCl Molecular weight: 350.87

This product is a capsule, and its contents are off-white or light yellow powder.

Used to treat duodenal ulcer, gastric ulcer, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.

Oral administration. Children aged 8 to 12 years old, take 1 capsule at a time. Children aged 12 years and above and adults, take 2 capsules at a time, twice a day. Take in the morning and before bedtime.

1 Common symptoms include: nausea, rash, constipation, fatigue, headache, dizziness, etc.; 2 Adverse reactions to renal function, gonadal function and central nervous system are relatively mild; 3 A small number of patients suffer from mild liver damage after taking the medicine, and the symptoms disappear after stopping the medicine, and liver function returns to normal.

It is forbidden to use for children under 18 years old; 2. It is forbidden to use for pregnant and lactating women.

Precautions for children: Not suitable for children under 8 years old Precautions for pregnancy and lactation: Not suitable for pregnant and lactating women Precautions for the elderly: The liver and kidney functions of the elderly are reduced. To ensure the safety of medication, the dosage should be adjusted.

1. When used with procainamide, the clearance rate of procainamide may be reduced; 2. If used with other drugs at the same time, drug interactions may occur. Please consult your physician or pharmacist for details.

Keep away from light, sealed and stored in a dry place.

0.15g (calculated as C13H22N4O3S)

24 months

Sanofi (Hangzhou) Pharmaceuticals Co., Ltd.

• Founded in:

  1995-11-30

• Address:

  No. 325, Jiangling Road, Binjiang District, Hangzhou City, Zhejiang Province

• Tax NO.:

  91330100609136127P

• Registered Funds:

  $28.8 million

• Website:

  Log in to view

• Email:

  Log in to view